More than 4,000 abstracts and 700 sessions covered the spectrum of basic, clinical, and population science.
Clinical Heart and Vascular Center
Physician Update 2022
The end of the year is always an exciting time at UT Southwestern. That’s because the findings we spotlight at the annual American Heart Association (AHA) Scientific Sessions – whether moderating, presenting new discoveries, or sharing clinical advances – fuels discussion beyond this remarkable conference well into the following year.
Be on the lookout for the printed version of this special issue of Physician Update, which will arrive in your mailboxes early in the year.
In the meantime, please enjoy the information contained in the reports linked below. It is our pleasure and privilege to make them available to you.
Featured Articles from Physician Update
Physician Update 2022
Initial Management of Critical Limb-Threatening Ischemia
By Joshua A. Beckman, M.D.
Effects of Tirzepatide on Ambulatory Blood Pressure and Heart Rate
By James de Lemos, M.D.
Longitudinal Assessment of Psychosocial Readiness in Heart Transplant Candidates
By Maryjane Farr, M.D., M.Sc.
In-Depth and Fresh Look at Heart Failure Clinical Trials
By Justin L. Grodin, M.D., M.P.H.
The ECMO-CS Trial: New Insights Into the Treatment of Cardiogenic Shock
By Amy E. Hackmann, M.D.
Circulation Symposium at #AHA22
By Joseph A. Hill, M.D., Ph.D.
Brady- and Tachyarrhythmias Following Heart Transplantation: Significance and Management Strategies
By Jose Joglar, M.D.
Diagnostic Delays in Patients with MI from Spontaneous Coronary Artery Dissection
By Dharam Kumbhani, M.D., S.M., and Laurette Mbuntum, M.D.
Impact of Deconditioning and Aerobic Reconditioning in POTS
By Benjamin D. Levine, M.D.
Assessing the Safety and Efficacy of High-Intensity Exercise Training for Patients with Hypertrophic Cardiomyopathy
By James P. MacNamara, M.D., M.S.C.S.
Highlights from ‘7 Questions About Cardiovascular Disease in Women: 2022 Edition’
By Rina Mauricio, M.D.
Resistant Hypertension and Social Determinants of Health
By Shawna D. Nesbitt, M.D., M.S.
Cardiac Rehabilitation and Heart Failure: An Opportunity to Improve Care
By Ambarish Pandey, M.D., M.S.C.S., and Neil Keshvani, M.D.
Size-Based HDL Particles and Cardiovascular Risk
By Anand Rohatgi, M.D., and Austin Deets, M.D.
Gender-Related Divergences in Cardiac and Vascular Function with Age
By Satyam Sarma, M.D., and Tiffany L. Brazile, M.D.
Immune Checkpoint Inhibitors and Myocardial Injury
By Vlad G. Zaha, M.D., Ph.D., and Anjali Rao, M.D.
Chimeric Antigen Receptor (CAR) T-Cell Therapy and Cardiovascular Risks
By Vlad G. Zaha, M.D., Ph.D., and Mahmoud Eljalby, M.D.
Explore Physician Update 2022:
- The ECMO-CS Trial: New Insights Into the Treatment of Cardiogenic Shock
- Chimeric Antigen Receptor (CAR) T-Cell Therapy and Cardiovascular Risks
- Two Impactful Heart Failure Trials
- Circulation Symposium at #AHA22
- Effects of Tirzepatide on Ambulatory Blood Pressure and Heart Rate
- Longitudinal Assessment of Psychosocial Readiness in Heart Transplant Candidates
- Brady- and Tachyarrhythmias Following Heart Transplantation: Significance and Management Strategies
- Highlights from ‘7 Questions About Cardiovascular Disease in Women: 2022 Edition’
- Cardiac Rehabilitation and Heart Failure: An Opportunity to Improve Care
- Size-Based HDL Particles and Cardiovascular Risk
- AHA Scientific Sessions 2022 – A Backstage View
- Fish Oil Supplements: Truth in Advertising?
- Initial Management of Critical Limb-Threatening Ischemia
- In-Depth and Fresh Look at Heart Failure Clinical Trials
- Diagnostic Delays in Patients with MI from Spontaneous Coronary Artery Dissection
- Assessing the Safety and Efficacy of High-Intensity Exercise Training for Patients with Hypertrophic Cardiomyopathy
- Impact of Deconditioning and Aerobic Reconditioning in POTS
- Resistant Hypertension and Social Determinants of Health
- Gender-Related Divergences in Cardiac and Vascular Function with Age
- Immune Checkpoint Inhibitors and Myocardial Injury